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The use of two kinase inhibitors (2i) enables deriva-
tion of mouse embryonic stem cells (ESCs) in the
pluripotent ground state. Using whole-genome bisul-
fite sequencing (WGBS), we show that male 2i ESCs
are globally hypomethylated compared to conven-
tional ESCs maintained in serum. In serum, female
ESCs are hypomethyated similarly to male ESCs in
2i, and DNA methylation is further reduced in 2i.
Regions with elevated DNAmethylation in 2i strongly
correlate with the presence of H3K9me3 on endoge-
nous retroviruses (ERVs) and imprinted loci. The
methylome of male ESCs in serum parallels postim-
plantation blastocyst cells, while 2i stalls ESCs in a
hypomethylated, ICM-like state. WGBS analysis dur-
ing adaptation of 2i ESCs to serum suggests that
deposition of DNA methylation is largely random,
while loss of DNA methylation during reversion to 2i
occurs passively, initiating at TET1 binding sites.
Together, our analysis provides insight into DNA
methylation dynamics in cultured ESCs paralleling
early developmental processes.
INTRODUCTION
Mouse ESCs are classically grown in media containing serum
either on feeder cells or supplemented with leukemia inhibitory
factor (LIF). These ESCs, here referred to as ‘‘serum ESCs,’’
are in a metastable state characterized by the expression of
many lineage-specifying genes (Graf and Stadtfeld, 2008; Haya-
shi et al., 2008; Loh and Lim, 2011; Marks et al., 2012). The use of
two small-molecule kinase inhibitors (2i) enabled derivation of
mouse ESCs in defined serum-free conditions (Ying et al.,
2008). The two inhibitors PD0325901 and CHIR99021 target360 Cell Stem Cell 13, 360–369, September 5, 2013 ª2013 Elsevier Imitogen-activated protein kinase (MEK) and glycogen synthase
kinase-3 (GSK3), respectively. ESCs established in 2i, referred
here as ‘‘2i ESCs,’’ are more homogeneous than serum ESCs
and are postulated to represent the ground state of pluripotency
(Ying et al., 2008). Recently, we showed that the transcriptome
and repressive histone mark H3K27me3, but not H3K9me3, is
markedly different and interconvertible between 2i and serum
ESCs upon simple exchange of growth media (Marks et al.,
2012). Serum ESCs are reported to contain high levels of DNA
methylation: globally, 4% of the cytosines are methylated
(Leitch et al., 2013; Stadler et al., 2011). This is most prominent
for CpG dinucleotides, which contain an average cytosine
methylation level of 80% (Stadler et al., 2011). As opposed to
the hypermethylated serum ESCs, recent analyses showed
that 2i ESCs are globally hypomethylated: only 1% of all cyto-
sines were reported to be methylated in 2i (Leitch et al., 2013).
DNA methylation is generally considered a relatively stable
mark. However, DNA methylation levels were shown to be
reversible between serum and 2i ESCs (Leitch et al., 2013). Since
these analyses were mainly performed using mass spectrom-
etry, the 2i ESC methylome is currently lacking.
In this study, we performed base-resolution whole-genome
bisulfite sequencing (WGBS) for 2i and serum ESCs, and did
so during interconversion of ESCs from 2i to serum and vice
versa. We further analyzed female ESCs, which in contrast to
male serum ESCs were reported to be globally hypomethylated
(Zvetkova et al., 2005). Our detailed genome-wide analysis of the
dynamics of deposition and removal of DNA methylation during
conversion of mouse ESCs at base-pair resolution provides
mechanistic insight into global (de)methylation and provides a
rich resource for future studies.RESULTS
Whole-Genome Bisulfite Analysis of 2i and Serum ESCs
We set out to define the DNA methylome of (1) one male
(E14) and two female (XT and LF2) ESC lines established andnc.
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same lines adapted to 2i and LIF (‘‘2i-adapted’’); and (3) one
ESC line derived and maintained in 2i and LIF (‘‘Rex/GFP-2i’’)
(Wray et al., 2011). In line with a recent study by (Leitch et al.,
2013), mass spectrometric (MS) quantification of 5-methylcyto-
sine (5mC) revealed a >3-fold global reduction in Rex/GFP-2i
ESCs and E14 2i-adapted as compared to E14 serum ESCs (Fig-
ure 1A). This is not caused by the heterogeneity of serum ESCs:
REX1-high and -low cells (Wray et al., 2011) within the serum
ESC population have similar, high DNA methylation levels (Fig-
ure 1B). Immunocytochemistry shows a low but homogeneous
staining of 5mC in 2i, and a markedly higher and more heteroge-
neous DNA methylation in serum ESCs (Figure 1C). In line with
a previous study (Zvetkova et al., 2005), the serum female lines
(XT and LF2) show reduced DNA methylation comparable to
that of male 2i ESCs. DNA methylation in these female ESCs is
further reduced upon adaptation to 2i (Figures 1A and Figure S1A
available online). The global levels of 5-hydroxymethylcytosine
(5hmC) are proportional to the 5mC levels (Figures 1A, 1B, and
S1A). Notably, Epistem cells (EpiSCs) have similarly high 5mC
levels that male serum ESCs do, but reduced 5hmC (Figure 1D).
To obtain DNA methylation levels at base-pair resolution, we
performed WGBS (Tables S1 and S2). In line with our MS anal-
ysis, 4.1% of all covered cytosines (71%) are methylated in
male serum ESCs, while methylation in the 2i ESCs and female
XT serum ESCs are much reduced (Figure 1E). In all ESC lines,
DNA methylation predominantly occurs at CpG dinucleotides,
while non-CpG methylation levels are very low (Figure S1B).
For both non-CpG and CpG methylation, we observed a strong
reduction in overall mean methylation levels in Rex/GFP-2i, E14
2i-adapted, and XT ESCs as compared to male E14 serum ESCs
(Figure S1B). In contrast to the 2i and female ESCs, the majority
of CpGs in E14 serum ESCs are hypermethylated (Figures 1F–
1H). Pairwise comparison over individual CpG sites further un-
derpins the strongly reduced methylation in the 2i and XT
ESCs, in which the majority of CpGs are hypomethylated (Fig-
ure 1I). Notably, the methylome of E14 serum ESCs is in full
concordance with the published WGBS DNA methylome (Sta-
dler et al., 2011) on a different serum ESC line called ‘‘159-2’’
(Pearson correlation 0.85; Figures 1F and 1I). Averaging of
the methylation signals shows a consistent loss of DNA methyl-
ation over CpG-island (CGI) promoters, enhancers, and bivalent
loci for the 2i and female ESCs as compared to male E14
serum ESCs (Figure 1J). Interestingly, the intermediate DNA
methylation state described previously at enhancers (Stadler
et al., 2011) is only apparent in male serum ESCs. Therefore
increased 5mC deposition at enhancers may not be counter-
acted in full by TETs (or other enzymes involved in demethylation)
in male serum ESCs (Kriaucionis and Heintz, 2009; Matarese
et al., 2011; Pastor et al., 2011; Tahiliani et al., 2009; Williams
et al., 2011).
2i ESCs Resemble Preimplantation Blastocyst Cells
In vivo, early mouse developmental stages up to the early
preimplantation blastocyst are hypomethylated, after which a
major wave of DNA methylation occurs (Meissner, 2010; Monk
et al., 1987; Santos et al., 2002). Our genome-wide bisulfite
sequencing of 2i ESCs indicated that DNA methylation in these
cells might parallel the hypomethylated state of inner cell massCell S(ICM) cells. Therefore, we compared our WGBS data with the
recently published restricted representation bisulfite sequencing
(RRBS) analysis of preimplantation ICM cells and the postim-
plantation stage E6.5 (Smith et al., 2012). The distribution of
CpG methylation in the ICM cells appears to be very similar to
that of male E14 2i-adapted, Rex/GFP-2i, and the female XT
(irrespective of the culture condition) with most of CpGs being
hypomethylated, but strikingly different from E14 serum ESCs
(Figures 2A and 2B). This is also reflected in the plotted CpG
methylation levels and the average methylation profiles over
CGI promoters (Figures 2C and S2A and Table S3). Comparison
of methylation levels of individual CpGs in ICM cells versus our
WGBS data of cultured ESCs (Figures 2D and S2B) reinforced
the idea that the methylation patterns of E14 2i-adapted, Rex/
GFP-2i, and XT ESCs reflect that of the preimplantation ICM.
Similar to the cultured 2i ESCs, staining of blastocysts shows
an even distribution of 5mC and 5hmC in ICM cells (Figure S2C).
The DNA methylome of male serum ESCs is very similar to the
RRBS data of the embryo proper of postimplantation stage
E6.5 (Figures 2 and S2). Our analysis shows that the E14 2i-
adapted DNA methylation pattern closely resembles that of the
ICM cells, further underpinning the biological significance of
the ground state 2i ESCs. The increased methylation from 2i to
serum might well reflect the global DNA methylation occurring
soon after the early blastocyst stage (Smith et al., 2012).
Remaining DNA Methylation in 2i ESCs Correlates with
H3K9me3
Our genome-wide bisulfite sequencing showed that the major
euchromatic part of the E14 2i-adapted, Rex/GFP-2i, and female
ESC genome is hypomethylated. Visual inspection revealed
small genomic patches with largely maintained DNAmethylation
as compared to serum ESCs (Figures 3A, S3A, and S3B). We
identified these regions, hereafter referred to as ‘‘maintained’’
regions, using a cut-off of E14_2i-adapted/E14_serum ratio
R 0.66 (Figure 3B and Table S4). In E14 2i-adapted ESCs, the
level of DNA methylation was slightly reduced at maintained re-
gions, but markedly declined over the flanks as compared to E14
serum ESCs (Figure 3C). In Rex/GFP-2i and (to a lesser extent)
the XT cells, these same maintained regions also display
elevated DNA methylation levels as compared to the mean
methylation levels in the euchromatic part of the genome. The
maintained regions are highly enriched for endogenous retrovi-
ruses (ERVs; Figures 3D and S3C), mainly of the intracisternal
A particle (IAP) type (Figure S3D). Targeted hairpin-bisulfite
amplicon sequencing (Arand et al., 2012) confirmed the largely
sustained DNA methylation over IAPs and to a lesser extent
satellites (Figure 3E). Interestingly, DNAmethylation at imprinted
control regions (ICRs) is maintained only in the male E14 2i-
adapted and Rex/GFP-2i ESCs, and not in female XT cells (Fig-
ure 3A). The significance of this conspicuous difference between
male and female ESCswith respect to overall level ofmethylation
and imprinting remains to be investigated.
Surprisingly, the global loss of DNA methylation upon adapta-
tion of E14 serum to 2i does not appear to be due to loss of
expression or activity of factors implicated in the so-called
maintenance methyltransferase pathway (Bostick et al., 2007;
Rothbart et al., 2012; Sharif et al., 2007). Transcript and pro-
tein levels, complex formation, and enzymatic activity of thetem Cell 13, 360–369, September 5, 2013 ª2013 Elsevier Inc. 361
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The Reversible Methylomes of Two Types of mESCsDNMT1/UHRF1/PCNA complex are not altered (Figures S3E–
S3G). Apparently, the continued activity of the DNMT1/UHRF1/
PCNA complex is not sufficient to sustain the hypermethylated
genome of E14 serum ESCs upon their being cultured in 2i.
Maintenance of DNA methylation by DNMT1/UHRF1/PCNA in
the 2i ESCs, in particular on ERVs, correlates with H3K9me3,
but not with H3K27me3 (Figure 3F) (Karimi et al., 2011; Matsui
et al., 2010; Rottach et al., 2010; Rowe et al., 2010). Furthermore,
regions of maintained DNA methylation and H3K9me3 levels
show very high correlation (Figure 3G), and H3K9me3 profiles
are very similar between 2i and serum ESCs (Figure 3H).
Together, our findings corroborate and extend previous reports
(Karimi et al., 2011; Matsui et al., 2010; Rottach et al., 2010;
Rowe et al., 2010) that maintenance of DNA methylation by the
DNMT1/UHRF1/PCNA pathway is dependent on the presence
of H3K9me3.
Recently, we showed that the de novo methyltransferases
DNMT3A and DNMT3B and their cofactor DNMT3L not only
contribute to the deposition of DNA methylation, but also play a
role in context-dependent maintenance of DNA methylation
(Arand et al., 2012). In 2i, transcript and protein levels of Dnmt3s
are much lower as compared to serum ESCs (Figures S3H–S3J),
in line with other reports (Leitch et al., 2013; Yamaji et al., 2013).
This suggests that the global DNA hypermethylation observed
in serum ESCs is due to elevated levels of DNMT3A, DNMT3B,
and DNMT3L. Importantly, expression levels of all Dnmt3 genes
are 10-fold upregulated during the transition from the early
(E3.5) to the late (E4.5) blastocyst stage (Tang et al., 2010), while
Dnmt1, Uhrf1, and Pcna expression levels remain constant, ex-
tendingourobservation to in vivodevelopment andstrengthening
the purported parallel between 2i and preimplantation ICM cells.
The Hypomethylated State in 2i Is Dependent on Both
Inhibitors and LIF
We next set out to investigate the contribution of the GSK inhib-
itor (CHIR99021), the MEK inhibitor (PD0325901), and LIF in
establishing the hypomethylated state observed in 2i ESCs.
Release of 2i ESCs from both inhibitors is accompanied by an
4-fold increase of DNA methylation within 5 days, upregulation
of Dnmt3a, Dnmt3b, and Dnmt3L, and concordant downregula-
tion of Prdm14, a reported repressor of Dnmt3a, Dnmt3b, and
Dnmt3L (Yamaji et al., 2013) (Figures 4A and 4B). Downregula-Figure 1. Ground State Pluripotent ESCs are Overall Hypomethylated,
(A) Total 5mC (left) or 5hmC (right) by mass spectrometry (MS). Data are presented
replicates).
(B) 5mC and 5hmC in the REX1-positive and -negative population within Rex/GFP
measurements).
(C) 5mC and 5hmC immunostainings of E14 serum and E14 2i-adapted ESCs; D
(D) 5mC and 5hmC in EpiSCs as in (A). Data are presented as mean ± SD (three
(E) Total 5(h)mC by WGBS. The WGBS profile of ‘‘159-2’’ ESCs was obtained fro
(F) Distribution of 5(h)mC levels in CpG sequence context byWGBS. The boxplot l
box represents median).
(G) A typical example depicting methylation profiles of the various ESCs. Meth
methylated), are shown by dots.
(H) Distribution of DNA methylation levels for individual CpGs genome-wide.
(I) Smoothed scatter plot between DNA methylation levels of individual CpGs gen
and black (high).
(J) Averaged methylation profiles over various functional genomic elements as c
See also Figure S1 and Tables S1 and S2.
Cell Stion of Nanog and Rex1 shows that the release from both
inhibitors results in loss of pluripotency in 2i ESCs as reported
previously (Figures 4B and S4A) (Wray et al., 2010). Removal of
CHIR99021, PD0325901, or LIF resulted in downregulation of
Prdm14, accompanied by upregulation of Dnmt3a, Dnmt3b,
and Dnmt3L. Pluripotency is retained in these conditions
(Wray et al., 2010), in line with continued high expression of
Nanog, Rex1, and Oct4. Consistent with the higher expression
levels of Dnmt3s, 5mC and 5hmC gradually increase within
7 days (Figure 4A). Adding serum on top of the 2i+LIF cultures
resulted in amarginal increase in DNA (hydroxy)methylation (Fig-
ure 4A). Taken together, the combined actions of CHIR99021,
PD0325901, and LIF are essential to maintain the hypomethy-
lated ground state of pluripotency in 2i ESCs.
Dynamics of Deposition of DNA Methylation during
Adaptation from 2i to Serum
To investigate the dynamics of DNA methylation, we determined
5mC/5hmC levels by MS during adaptation from 2i to serum. For
both E14 2i-adapted and Rex/GFP-2i, 5mC and 5hmC remain
constant for 24 hr during reversion to serum but are significantly
increased by day 3, reaching a plateau at day 7 (Figure 4C: right
panels, Figures S4E and S4F). To gain further insight, we
performed WGBS analysis at days 1, 3, 5, and 7 of serum adap-
tation. The kinetics of DNA methylation determined by WGBS
(Figures 4F, 4G, S4G, and S4H) is in good agreement with the
MS measurements and hairpin BS-seq (Figures S4I and S4J).
K-means clustering of average methylation levels over 1 kb
genomic intervals during adaptation from 2i to serum revealed
little difference between the clusters (Figure 4I), hinting at
random DNA methylation deposition. Interestingly, a subset of
so-called maintained regions decorated with H3K9me3 also
seem to temporally demethylate during adaptation to serum
(Figure 4I: cluster 4), although DNA methylation is preserved at
the majority of the maintained regions (Figure 4G).
Dynamics of Demethylation upon Reversion from
Serum to 2i
DNA demethylation during adaptation from serum to 2i becomes
apparent only after 3 days and gradually reaches steady state
‘‘2i-levels’’ by day 12, with 5hmC proportional to 5mC levels dur-
ing adaptation (Figure 4C: left panels). By contrast, a markedas Opposed to Hypermethylated Male Serum ESCs
as mean ± SD (MSmeasurements for three or two [female ESCs] independent
-serum ESCs, as in (A). Data are presented asmean ± SD (four independentMS
API staining in blue.
independent MS measurements).
m a previous study (Stadler et al., 2011).
ayout is according to the Tukey five-number summary (horizontal line within the
ylation levels of individual CpG sites, between 0 (unmethylated) and 1 (fully
ome-wide. Density of data points ranges from yellow (low) to red (intermediate)
haracterized in E14 serum.
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Figure 2. The Hypomethylated 2i ESCs Resemble ICM Cells (E3.5), while Male Serum ESCs Are Reminiscent of the Hypermethylated E6.5
Mouse Embryo Proper
(A and B) Distribution of CpGmethylation levels for all CpGs covered by in vivo RRBSmethylation assays (Smith et al., 2012) for ICM cells (E3.5) and E6.5 cells (A)
and the corresponding CpGs in WGBS of ESCs (this study; B).
(C) Averaged methylation profiles over CpG island promoters (CGI).
(D) Smoothed scatter plots of methylation levels between CpGs of cultured ESCs (WGBS) versus in vivo developmental stages (RRBS) as in Figure 1I.
See also Figure S2 and Table S3.
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The Reversible Methylomes of Two Types of mESCsdrop in transcript levels of Dnmt3a, Dnmt3b, and Dnmt3L is
already apparent after 2 hr and levels off after24 hr (Figure 4D),
concordant with upregulation of Prdm14. The delay in global de-
methylation as compared to reduced expression of the Dnmt3
genes might well be explained by a long half-life of DNMT3 pro-364 Cell Stem Cell 13, 360–369, September 5, 2013 ª2013 Elsevier Iteins. Although starting from lower methylation levels, female
cells behaved very similarly (Figures 4E, S4C, and S4D). The ob-
servations that demethylation takes12 days (equivalent to18
cell divisions) and that expression of the Tet genes remains con-
stant (Figure S4B) suggests that under our conditions, globalnc.
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K-means clustering on WGBS profiles generated at days 1, 7
(midway), and 17 identified one cluster with loss of methylation
already apparent at 24 hr of adaptation (Figure 4H). The genomic
loci in cluster 4 are enriched for active promoters and enhancers
as well as for TET1 occupancy. This suggests that demethylation
is initiated at TET1 binding sites and subsequently spreads to the
remainder of the genome. Even though TET1 appears to have an
active role, demethylation at the TET binding sites and in partic-
ular for the remainder of methylated cytosines remains slow and
is only completed after 12 days.DISCUSSION
Recent analyses of the DNAmethylome of early mouse develop-
mental stages using RRBS (Smith et al., 2012) and WGBS of
serum ESCs (Stadler et al., 2011) revealed a marked discrep-
ancy: ICM cells from preimplantation embryos are hypomethy-
lated, whereas serum ESCs are globally hypermethylated. We
use WGBS profiling to show that ESCs cultured in 2i are hypo-
methylated and closely parallel hypomethylated ICM cells.
Regions of maintained DNA methylation in 2i highly correlate
with the presence of H3K9me3. Serum conditions appear to
cause a genome-wide de novo methylation in ESCs accompa-
nied by enhanced levels of DNMT3a, DNMT3b, and DNMT3L.
Our WGBS analysis suggests that this de novo methylation
occurs stochastically, but currently we cannot exclude the pos-
sibility of initiation at methylation centers with subsequent
spread across larger regions. Conversely we find that adaptation
from serum to 2i is biphasic: demethylation initially occurs
locally, likely triggered by TET1 at its genomic binding sites,
with subsequent genome-wide demethylation likely occurring
passively. Female ESCs already contain low methylation levels
in serum, which might be the cause of their genomic instability
as reported previously (Chen et al., 1998). Altogether, our
WGBS profiling provides mechanistic insight into the dynamics
of genome-wide de novo methylation occurring during transition
of the 2i ESC ground state to serum and the demethylation
occurring during the reverse transition.EXPERIMENTAL PROCEDURES
Cell Culture
ESCs were cultured without feeders in the presence of LIF either in DMEM
containing 10% fetal calf serum or in serum-free NDiff 227 (StemCells, Inc.)
supplemented with MEK inhibitor PD0325901 (1 mM) and GSK3 inhibitorFigure 3. Maintained DNA Methylation in 2i ESCs Correlates with H3K
(A) Typical example of methylation profiles across maintained regions as in Fig
islands; blue triangle (‘‘ICR’’): imprinted control region. The zoom-ins show an imp
H3K9me3 occupancies and female XT ESC WGBS profiles.
(B) Smoothed scatter plot over maintained regions; color setting as in Figure 1I.
(C) Averaged DNA methylation levels over maintained regions.
(D) Enrichment of repeat families and classes within the maintained regions.
(E) Hairpin-bisulfite amplicon sequencing over CpGs in various repeats and gene
(F) Averaged H3K9me3 and H3K27me3 levels (matched for serum and 2i ESCs)
(G) Correlation betweenH3K9me3 occupancies (x axis) and degree of maintenanc
are indicated in green.
(H) Smoothed scatter plot of H3K9me3 over maintained regions showing high si
See also Figure S3 and Table S4.
366 Cell Stem Cell 13, 360–369, September 5, 2013 ª2013 Elsevier ICHIR99021 (3 mM), together known as 2i (Ying et al., 2008). E14Tg2a are
male ESCs of 129 background established in serum and LIF. Rex/GFP-2i
ESCs (129) contain a monoallelic green fluorescent protein (GFPd2) knockin
at the Rex1 (Zfp42) locus (Wray et al., 2011) and were derived in 2i and LIF.
EpiSCs (Maruotti et al., 2010) and female XT (XT67E1) and LF2 ESCs have
been described (Marks et al., 2009).
WGBS and Hairpin-Bisulfite Amplicon Sequencing
DNA was isolated using standard phenol/chloroform extraction and ethanol
precipitation or using the Cell Culture DNA Midi Kit from QIAGEN (Cat No
13343). WGBS was performed as described previously (Kulis et al., 2012).
We performed paired-end DNA sequencing (2*100 nucleotides) using the
Illumina Hi-Seq 2000. All sequencing analyses were conducted based on the
Mus musculus NCBI m37 genome assembly (MM9). Sequencing statistics are
shown in Table S1. All WGBS data (FASTQ and bedGraph files) are present at
NCBI GEO SuperSeries GSE41923. Targeted hairpin-bisulfite amplicon
sequencing was performed as described (Arand et al., 2012) with slight mod-
ifications as follows: BsaWI was used as the restriction enzyme for L1, and for
IAP we used TTTTTTTTTTAGGAGAGTTATATTT and ATCACTCCCTAAT
TAACTACAAC primers using 40 cycles of 95C (10), 51C (1.50), and 72C
(10) for PCR amplification. Amplicons were sequenced with GS FLX Titanium
or Illumina MiSeq.
Read Mapping and Calculation of Cytosine Methylation
FASTQsequence fileswere aligned usingRMAPBS (Smith et al., 2009) allowing
amaximumof 10mismatches for efficientmapping of reads containing bisulfite
converted unmethylated cytosines. Cytosine methylation levels were deter-
mined using a new pipeline developed by the Smith lab (MethPipe; http://
smithlab.usc.edu/). In short, both mates of the paired-end sequencing were
mapped separately by RMAPBS. Readsmapping equally well onmultiple posi-
tionson thegenomewereexcluded from further analysis.Matesmappingwithin
a maximum distance of 500 bp were merged and other reads were excluded
from further analysis. If multiple mated reads mapped on exactly the same
genomic coordinates (duplicates), all but one were discarded. Within a CpG
context, symmetric cytosines on both forward and reverse strands were com-
bined. Cytosine methylation level was called per individual C as #C/(#C + #T).
WGBS, RRBS-seq, ChIP-seq, and RNA-seq Data Sets
FASTQ data for ‘‘159-2’’ serum ESCs (Stadler et al., 2011) was downloaded
from GSE30206 and analyzed as described above. In vivo FASTQ RRBS
sequencing data (Smith et al., 2012) was downloaded from GSE34864. These
FASTQ files were mapped against mm9 using RRBSMAP (Xi et al., 2012) and
merged. Within the 36 bp single end reads, three mismatches were allowed.
RRMAPBS reports one random hit in case a readmaps equally well onmultiple
locations. In case of duplicate reads, all were included for further analysis.
Within a CpG context, symmetric cytosines on both forward and reverse
strands were combined. Cytosinemethylation level was calculated per individ-
ual C by a script included in RRBSMAP.
H3K4me1 ChIP-seq data was obtained from GSE30206 (Stadler et al.,
2011), H3K27ac from GSM594578 (Creyghton et al., 2010), Tet1 from
GSE24843 (Williams et al., 2011), and all other ChIP-seq data/RNA-seq from
GSE23943 (Marks et al., 2012). DNaseI hypersensitive sites (Celniker et al.,
2009) were downloaded from the UCSC genome browser.9me3 in Regions such as ERVs
ure 1G. Red boxes (‘‘maint’’): maintained regions; green boxes (‘‘CGI’’): CpG
rinted region (Peg10/Sgce) and an additional gene locus (Dync1i1) and include
s, represented as described previously (Arand et al., 2012).
over maintained regions.
e of DNAmethylation in 2i (y axis; 0 = fully maintained). 25th and 75th percentiles
milarity between E14 serum and 2i-adapted. Color settings as in Figure 1I.
nc.
(legend on next page)
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The Reversible Methylomes of Two Types of mESCsWe determined enhancers by H3K4me1, H3K27ac, and DNaseI hypersensi-
tivity in E14 serum ESCs as described (Zentner et al., 2011). Bivalent loci were
defined as co-occurring active H3K4me3 and repressive H3K27me3 marks in
E14 serum ESCs.
Data Analysis
For WGBS of E14 serum, E14 2i-adapted, and Rex/GFP-2i, a CpG coverage
threshold of R10 was used; for other profiles the threshold was R5. For
WGBS and RRBS comparisons, we included common CpGs with a coverage
R5 in the RRBS data. For the analysis of RRBS data and the corresponding
WGBS data, CpGs were binned (36 bp) for analysis. CGI promoters were
defined as promoters (2 kb to +0.5 kb relative to the transcription start
site) overlapping with a CGI (UCSC genome browser CpG island). For average
plots, average values in 100 bp bins were calculated and plotted. Regions of
maintained DNA methylation in 2i were intersected with repeats as annotated
in RepeatMask (mm9). The frequencies within this intersection were compared
to the full repeat data set to obtain an observed/expected ratio for each repeat.
Probabilities were calculated using a Fisher’s exact test.
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